Table 2.
Diseases | Before COVID-19 | During COVID-19 | p-Values of Difference | |||
---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | Variance | |
Men | ||||||
Autism | 2595.8 | 201.1 | 2960.7 | 288.3 | <0.001 * | 0.892 |
ADHD | 21881.1 | 2099.7 | 23093.9 | 1780.9 | 0.093 | 0.187 |
Depressive disorder | 5427.6 | 630.5 | 5929.5 | 585.5 | 0.014 * | 0.709 |
Bipolar disorder | 929.0 | 91.7 | 1054.8 | 44.4 | <0.001 * | 0.263 |
Primary insomnia | 281.3 | 39.5 | 271.7 | 32.3 | 0.379 | 0.763 |
Schizophrenia | 594.3 | 24.1 | 503.8 | 13.9 | <0.001 * | 0.014 † |
Panic disorder | 469.8 | 58.6 | 643.7 | 78.8 | <0.001 * | 0.113 |
Hypochondriasis | 10.0 | 3.4 | 14.1 | 3.4 | 0.001 * | 0.871 |
Post traumatic stress disorder | 158.8 | 17.1 | 170.3 | 17.8 | 0.066 | 0.762 |
Anxiety disorder | 2663.4 | 255.7 | 3186.3 | 411.4 | <0.001 * | 0.542 |
Anorexia nervosa | 13.0 | 2.9 | 12.2 | 3.0 | 0.295 | 0.611 |
Adephagia | 12.6 | 5.0 | 11.0 | 3.0 | 0.497 | 0.443 |
Women | ||||||
Autism | 474.8 | 44.6 | 589.9 | 71.8 | <0.001 * | 0.353 |
ADHD | 4617.1 | 507.0 | 5573.9 | 562.3 | <0.001 * | 0.425 |
Depressive disorder | 8845.5 | 1416.1 | 9819.5 | 1074.3 | 0.021 * | 0.973 |
Bipolar disorder | 1067.0 | 148.0 | 1361.9 | 98.2 | <0.001 * | 0.101 |
Primary insomnia | 294.2 | 44.3 | 312.2 | 21.9 | 0.159 | 0.003 † |
Schizophrenia | 572.1 | 27.9 | 485.3 | 10.7 | <0.001 * | 0.017 † |
Panic disorder | 588.2 | 100.7 | 863.4 | 137.4 | <0.001 * | 0.165 |
Hypochondriasis | 5.6 | 2.4 | 12.2 | 8.1 | 0.006 * | 0.727 |
Post traumatic stress disorder | 257.4 | 28.5 | 295.3 | 29.0 | <0.001 * | 0.777 |
Anxiety disorder | 2873.2 | 422.4 | 3716.3 | 585.5 | <0.001 * | 0.898 |
Anorexia nervosa | 93.4 | 10.0 | 114.9 | 23.4 | 0.003 * | 0.081 |
Adephagia | 66.5 | 9.6 | 69.6 | 8.1 | 0.464 | 0.828 |
* Mann–Whitney U test, significance at <0.05, † Levene’s test in non-parametric data, significance at <0.05.